5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation
- PMID: 16159627
- DOI: 10.1016/j.jaci.2005.04.029
5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation
Abstract
Background: 5-Lipoxygenase (5-LO) products have been strongly implicated in the pathogenesis of allergic diseases. In addition to their physiologic effects on residential cells, 5-LO products are capable of stimulating various eosinophil functions. However, little is known regarding the effects of 5-LO products on basophil functions.
Objective: This study was designed to elucidate the effects of the main 5-LO products (ie, leukotriene [LT] B(4), LTD(4), and 5-oxo-6,8,11,14-eicosatetraenoic acid [5-oxo-ETE]), as well as their receptor expression on human basophils.
Methods: We studied the effects of 5-LO products on Ca(2+) mobilization, migration, CD 11b expression, and degranulation of human basophils. Expression of the receptors for LTC(4)/D(4)/E(4) (cysteinyl leukotriene 1 [CysLT(1)] and CysLT(2)), LTB4 (BLT(1) and BLT(2)), and 5-oxo-ETE (oxoeicosanoid [OXE]) was assessed by means of real-time PCR and flow cytometry.
Results: At the mRNA level, basophils strongly expressed OXE and predominantly expressed CysLT(1) and BLT(2). The expression level of OXE mRNA in basophils was approximately 20-fold higher than in neutrophils and similar to that in eosinophils. At the protein level, basophils expressed CysLT(1), CysLT(2), BLT(1), and OXE, but not BLT(2). All products elicited a transient increase of cytosolic calcium, with the order of magnitude being LTB(4)>5-oxo-ETE>LTD(4). 5-Oxo-ETE induced a strong basophil migratory response that was almost equivalent to that of prostaglandin D(2). LTB(4) elicited significant degranulation of IL-3-primed basophils. In contrast, no functional significance was observed for LTD(4).
Conclusion: Among 5-LO products, 5-oxo-ETE induces a potent basophil migratory response, and LTB(4) elicits degranulation under certain conditions. Our results strongly suggest that 5-oxo-ETE might afford opportunities for therapeutic targeting in allergic inflammation.
Similar articles
-
Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity.J Pharmacol Exp Ther. 2008 May;325(2):698-707. doi: 10.1124/jpet.107.134908. Epub 2008 Feb 21. J Pharmacol Exp Ther. 2008. PMID: 18292294
-
Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils.J Pharmacol Exp Ther. 2005 Feb;312(2):627-34. doi: 10.1124/jpet.104.074823. Epub 2004 Sep 23. J Pharmacol Exp Ther. 2005. PMID: 15388786
-
Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.Prog Lipid Res. 2005 Mar-May;44(2-3):154-83. doi: 10.1016/j.plipres.2005.04.002. Epub 2005 Apr 20. Prog Lipid Res. 2005. PMID: 15893379 Review.
-
Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.Prostaglandins Other Lipid Mediat. 2007 May;83(3):188-97. doi: 10.1016/j.prostaglandins.2007.01.005. Epub 2007 Jan 17. Prostaglandins Other Lipid Mediat. 2007. PMID: 17481554 Review.
-
Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.J Allergy Clin Immunol. 2006 Jul;118(1):113-9. doi: 10.1016/j.jaci.2006.03.010. Epub 2006 May 19. J Allergy Clin Immunol. 2006. PMID: 16815146
Cited by
-
Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates.Br J Pharmacol. 2022 Jan;179(2):322-336. doi: 10.1111/bph.15721. Epub 2021 Dec 16. Br J Pharmacol. 2022. PMID: 34766334 Free PMC article.
-
Targeting the OXE receptor as a potential novel therapy for asthma.Biochem Pharmacol. 2020 Sep;179:113930. doi: 10.1016/j.bcp.2020.113930. Epub 2020 Mar 30. Biochem Pharmacol. 2020. PMID: 32240653 Free PMC article. Review.
-
Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys.Br J Pharmacol. 2020 Jan;177(2):388-401. doi: 10.1111/bph.14874. Epub 2020 Jan 17. Br J Pharmacol. 2020. PMID: 31655025 Free PMC article.
-
Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non-human primates.Br J Pharmacol. 2020 Jan;177(2):360-371. doi: 10.1111/bph.14872. Epub 2020 Jan 17. Br J Pharmacol. 2020. PMID: 31655023 Free PMC article.
-
5-oxo-ETE activates migration of H295R adrenocortical cells via MAPK and PKC pathways.Prostaglandins Other Lipid Mediat. 2019 Oct;144:106346. doi: 10.1016/j.prostaglandins.2019.106346. Epub 2019 Jul 10. Prostaglandins Other Lipid Mediat. 2019. PMID: 31301403 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous